FatPipe (FATN) shares surged over 200% in their trading debut on Nasdaq Tuesday after the company priced its initial public offering of 695,656 shares at $5.75 apiece to raise about $4 million.
60 Degrees Pharmaceuticals (SXTP) said it signed a patent license deal with Yale School of Medicine and Yale School of Public Health to jointly develop and commercialize Tafenoquine for the treatment and prevention of tick-borne disease babesiosis.
Shares surged 64%, with intraday trading volume catapulted to over 73.8 million from a daily average of about 419,000.
Price: 18.25, Change: +12.50, Percent Change: +217.30
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.